These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 17260091

  • 1. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
    Macis D, Maisonneuve P, Johansson H, Bonanni B, Botteri E, Iodice S, Santillo B, Penco S, Gucciardo G, D'Aiuto G, Rosselli Del Turco M, Amadori M, Costa A, Decensi A.
    Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
    [Abstract] [Full Text] [Related]

  • 2. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
    Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY, Sun CA.
    Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
    [Abstract] [Full Text] [Related]

  • 3. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
    Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763
    [Abstract] [Full Text] [Related]

  • 4. The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan.
    Lin WY, Chou YC, Wu MH, Huang HB, Jeng YL, Wu CC, Yu CP, Yu JC, You SL, Chu TY, Chen CJ, Sun CA.
    Anticancer Res; 2004 Dec; 24(6):3863-8. PubMed ID: 15736423
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
    Langsenlehner T, Renner W, Yazdani-Biuki B, Langsenlehner U.
    Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
    Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K.
    Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study.
    Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE.
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1198-203. PubMed ID: 15894672
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population.
    Deligezer U, Akisik EE, Dalay N.
    In Vivo; 2005 May; 19(5):889-93. PubMed ID: 16097444
    [Abstract] [Full Text] [Related]

  • 14. The methylenetetrahydrofolate reductase 677C-->T polymorphism and lung cancer risk in a Chinese population.
    Jeng YL, Wu MH, Huang HB, Lin WY, You SL, Chu TY, Chen CJ, Sun CA.
    Anticancer Res; 2003 May; 23(6D):5149-52. PubMed ID: 14981981
    [Abstract] [Full Text] [Related]

  • 15. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.
    Lewis SJ, Harbord RM, Harris R, Smith GD.
    J Natl Cancer Inst; 2006 Nov 15; 98(22):1607-22. PubMed ID: 17105984
    [Abstract] [Full Text] [Related]

  • 16. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
    Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM.
    Cancer Epidemiol Biomarkers Prev; 2005 Jun 15; 14(6):1470-6. PubMed ID: 15941958
    [Abstract] [Full Text] [Related]

  • 17. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
    Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Santella RM.
    Cancer Res; 2005 Feb 15; 65(4):1606-14. PubMed ID: 15735051
    [Abstract] [Full Text] [Related]

  • 18. Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene.
    Beilby J, Ingram D, Hähnel R, Rossi E.
    Eur J Cancer; 2004 May 15; 40(8):1250-4. PubMed ID: 15110890
    [Abstract] [Full Text] [Related]

  • 19. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
    Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiński J, Scott RJ, Hamann U.
    Breast Cancer Res Treat; 2007 Sep 15; 104(3):299-308. PubMed ID: 17063264
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.